# NewYork–Presbyterian Brooklyn Methodist Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/newyork-presbyterian-brooklyn-methodist-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 96 |
| Citations | 155,354 |
| City | Brooklyn |
| Country | US |
| Description | NewYork–Presbyterian Brooklyn Methodist Hospital is a research organisation in Brooklyn, US. OpenAlex records 3,866 works and 155,354 citations for it. 1,445 researchers list it as their most recent affiliation. |
| Homepage | https://www.nyp.org/brooklyn |
| OpenAlex ID | https://openalex.org/I1341523491 |
| Region | New York |
| Researchers | 1,445 |
| ROR ID | https://ror.org/04929s478 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q14707083 |
| Works | 3,866 |

## University papers

- [Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer](https://scholariq.org/papers/response-to-neoadjuvant-therapy-and-long-term-survival-in-patients-with-triple/)
- [Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by <i>HER2</i> Immunophenotype and Gene Amplification](https://scholariq.org/papers/weekly-trastuzumab-and-paclitaxel-therapy-for-metastatic-breast-cancer-with/)
- [International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment](https://scholariq.org/papers/international-expert-panel-on-inflammatory-breast-cancer-consensus-statement-for/)
- [Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes](https://scholariq.org/papers/invasive-lobular-carcinoma-classic-type-response-to-primary-chemotherapy-and/)
- [Inflammatory Breast Cancer: The Disease, the Biology, the Treatment](https://scholariq.org/papers/inflammatory-breast-cancer-the-disease-the-biology-the-treatment/)
- [Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer](https://scholariq.org/papers/response-to-neoadjuvant-therapy-and-long-term-survival-in-patients-with-triple-2/)
- [ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer](https://scholariq.org/papers/icam1-initiates-ctc-cluster-formation-and-trans-endothelial-migration-in-lung/)
- [Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/tucidinostat-plus-exemestane-for-postmenopausal-patients-with-advanced-hormone/)
- [Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)](https://scholariq.org/papers/challenges-and-opportunities-of-cfdna-analysis-implementation-in-clinical/)

## University top topics

Showing 8 of 25.

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiac, Anesthesia and Surgical Outcomes](https://scholariq.org/topics/cardiac-anesthesia-and-surgical-outcomes/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.